Slc25a30 Rat (1->4)-beta-D-glucan multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC25A30 mRNA CTD PMID:36331819 Slc25a30 Rat 1,2-dichloroethane decreases expression ISO Slc25a30 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of SLC25A30 mRNA CTD PMID:28960355 Slc25a30 Rat 1,2-dimethylhydrazine increases expression ISO Slc25a30 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of SLC25A30 mRNA CTD PMID:22206623 Slc25a30 Rat 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of SLC25A30 mRNA CTD PMID:25380136 and PMID:30723492 Slc25a30 Rat 17beta-estradiol decreases expression ISO SLC25A30 (Homo sapiens) 6480464 Estradiol results in decreased expression of SLC25A30 mRNA CTD PMID:21185374 Slc25a30 Rat 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of SLC25A30 mRNA CTD PMID:35192832 Slc25a30 Rat 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of SLC25A30 mRNA CTD PMID:32145629 Slc25a30 Rat 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 Slc25a30 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in decreased expression of SLC25A30 mRNA CTD PMID:19465110 Slc25a30 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC25A30 mRNA CTD PMID:26232522 and PMID:33387578 Slc25a30 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO SLC25A30 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC25A30 mRNA CTD PMID:20106945 and PMID:21632981 Slc25a30 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc25a30 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC25A30 mRNA CTD PMID:21570461 and PMID:28922406 Slc25a30 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Slc25a30 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC25A30 mRNA CTD PMID:19770486 and PMID:21889950 Slc25a30 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Slc25a30 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC25A30 mRNA CTD PMID:18172886 Slc25a30 Rat 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of SLC25A30 mRNA CTD PMID:21346803 Slc25a30 Rat 2-hydroxypropanoic acid decreases expression ISO SLC25A30 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of SLC25A30 mRNA CTD PMID:30851411 Slc25a30 Rat 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of SLC25A30 mRNA CTD PMID:25380136 Slc25a30 Rat 4,4'-sulfonyldiphenol affects expression ISO Slc25a30 (Mus musculus) 6480464 bisphenol S affects the expression of SLC25A30 mRNA CTD PMID:39298647 Slc25a30 Rat 4,4'-sulfonyldiphenol increases expression ISO Slc25a30 (Mus musculus) 6480464 bisphenol S results in increased expression of SLC25A30 mRNA CTD PMID:33297965 Slc25a30 Rat acrylamide affects expression EXP 6480464 Acrylamide affects the expression of SLC25A30 mRNA CTD PMID:28959563 Slc25a30 Rat Actein decreases expression EXP 6480464 actein results in decreased expression of SLC25A30 protein CTD PMID:29969672 Slc25a30 Rat aflatoxin B1 increases expression ISO Slc25a30 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of SLC25A30 mRNA CTD PMID:19770486 Slc25a30 Rat aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of SLC25A30 mRNA CTD PMID:25378103 Slc25a30 Rat alpha-Zearalanol multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SLC25A30 mRNA CTD PMID:35163327 Slc25a30 Rat amiodarone increases expression ISO SLC25A30 (Homo sapiens) 6480464 Amiodarone results in increased expression of SLC25A30 mRNA CTD PMID:19774075 Slc25a30 Rat arsane multiple interactions ISO SLC25A30 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC25A30 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC25A30 mRNA CTD PMID:39836092 Slc25a30 Rat arsenic atom multiple interactions ISO SLC25A30 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC25A30 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC25A30 mRNA CTD PMID:39836092 Slc25a30 Rat atrazine affects methylation EXP 6480464 Atrazine affects the methylation of SLC25A30 gene CTD PMID:35440735 Slc25a30 Rat benzo[a]pyrene decreases expression ISO Slc25a30 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of SLC25A30 mRNA CTD PMID:19770486 and PMID:32417428 Slc25a30 Rat benzo[a]pyrene decreases expression ISO SLC25A30 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SLC25A30 mRNA CTD PMID:32234424 Slc25a30 Rat benzo[a]pyrene increases methylation ISO SLC25A30 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of SLC25A30 promoter CTD PMID:27901495 Slc25a30 Rat benzo[a]pyrene affects methylation ISO SLC25A30 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLC25A30 5' UTR CTD PMID:27901495 Slc25a30 Rat bisphenol A decreases expression ISO Slc25a30 (Mus musculus) 6480464 bisphenol A results in decreased expression of SLC25A30 mRNA CTD PMID:26063408 Slc25a30 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC25A30 mRNA CTD PMID:35192832 Slc25a30 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC25A30 mRNA CTD PMID:25181051 more ... Slc25a30 Rat bisphenol F increases expression ISO Slc25a30 (Mus musculus) 6480464 bisphenol F results in increased expression of SLC25A30 mRNA CTD PMID:38685157 Slc25a30 Rat bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of SLC25A30 mRNA CTD PMID:32479839 Slc25a30 Rat chlorpyrifos decreases expression ISO Slc25a30 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of SLC25A30 mRNA CTD PMID:37019170 Slc25a30 Rat choline multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SLC25A30 mRNA CTD PMID:33549593 Slc25a30 Rat cisplatin increases expression ISO SLC25A30 (Homo sapiens) 6480464 Cisplatin results in increased expression of SLC25A30 mRNA CTD PMID:27392435 Slc25a30 Rat clofibrate increases expression ISO Slc25a30 (Mus musculus) 6480464 Clofibrate results in increased expression of SLC25A30 mRNA CTD PMID:23811191 Slc25a30 Rat clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of SLC25A30 mRNA CTD PMID:32741897 Slc25a30 Rat crocidolite asbestos decreases expression ISO Slc25a30 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of SLC25A30 mRNA CTD PMID:29279043 Slc25a30 Rat cyanocob(III)alamin multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SLC25A30 mRNA CTD PMID:33549593 Slc25a30 Rat cyclosporin A decreases expression ISO SLC25A30 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of SLC25A30 mRNA CTD PMID:25562108 Slc25a30 Rat decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of SLC25A30 mRNA CTD PMID:23640034 Slc25a30 Rat dexamethasone increases expression ISO Slc25a30 (Mus musculus) 6480464 Dexamethasone results in increased expression of SLC25A30 mRNA CTD PMID:22733784 Slc25a30 Rat Dibutyl phosphate affects expression ISO SLC25A30 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of SLC25A30 mRNA CTD PMID:37042841 Slc25a30 Rat dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of SLC25A30 mRNA CTD PMID:21266533 Slc25a30 Rat dichloroacetic acid increases expression ISO Slc25a30 (Mus musculus) 6480464 Dichloroacetic Acid results in increased expression of SLC25A30 mRNA CTD PMID:28962523 Slc25a30 Rat diclofenac decreases expression ISO Slc25a30 (Mus musculus) 6480464 Diclofenac results in decreased expression of SLC25A30 mRNA CTD PMID:26934552 Slc25a30 Rat diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of SLC25A30 mRNA CTD PMID:17005392 Slc25a30 Rat disodium selenite increases expression ISO SLC25A30 (Homo sapiens) 6480464 Sodium Selenite results in increased expression of SLC25A30 mRNA CTD PMID:24383545 Slc25a30 Rat diuron increases expression EXP 6480464 Diuron results in increased expression of SLC25A30 mRNA CTD PMID:21551480 Slc25a30 Rat dorsomorphin multiple interactions ISO SLC25A30 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A30 mRNA CTD PMID:27188386 Slc25a30 Rat entinostat increases expression ISO SLC25A30 (Homo sapiens) 6480464 entinostat results in increased expression of SLC25A30 mRNA CTD PMID:27188386 Slc25a30 Rat epoxiconazole affects expression ISO Slc25a30 (Mus musculus) 6480464 epoxiconazole affects the expression of SLC25A30 mRNA CTD PMID:35436446 Slc25a30 Rat fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of SLC25A30 mRNA CTD PMID:32741897 Slc25a30 Rat fluoranthene multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC25A30 mRNA CTD PMID:28329830 Slc25a30 Rat flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SLC25A30 mRNA CTD PMID:24136188 Slc25a30 Rat folic acid multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SLC25A30 mRNA CTD PMID:33549593 Slc25a30 Rat furan decreases expression EXP 6480464 furan results in decreased expression of SLC25A30 mRNA CTD PMID:26194646 Slc25a30 Rat gamma-hexachlorocyclohexane decreases expression EXP 6480464 Hexachlorocyclohexane results in decreased expression of SLC25A30 mRNA CTD PMID:17785943 Slc25a30 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLC25A30 mRNA CTD PMID:33387578 Slc25a30 Rat glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of SLC25A30 mRNA CTD PMID:24136188 Slc25a30 Rat glycine betaine multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SLC25A30 mRNA CTD PMID:33549593 Slc25a30 Rat indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SLC25A30 mRNA CTD PMID:22129741 Slc25a30 Rat inulin multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC25A30 mRNA CTD PMID:36331819 Slc25a30 Rat isoprenaline increases expression ISO Slc25a30 (Mus musculus) 6480464 Isoproterenol results in increased expression of SLC25A30 mRNA CTD PMID:20003209 Slc25a30 Rat L-methionine multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SLC25A30 mRNA CTD PMID:33549593 Slc25a30 Rat manganese atom multiple interactions ISO SLC25A30 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC25A30 mRNA and [manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC25A30 mRNA CTD PMID:39836092 Slc25a30 Rat manganese(0) multiple interactions ISO SLC25A30 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC25A30 mRNA and [manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC25A30 mRNA CTD PMID:39836092 Slc25a30 Rat manganese(II) chloride multiple interactions ISO SLC25A30 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC25A30 mRNA and [manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC25A30 mRNA CTD PMID:39836092 Slc25a30 Rat methylmercury chloride decreases expression ISO SLC25A30 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of SLC25A30 mRNA CTD PMID:23179753 and PMID:27188386 Slc25a30 Rat mono(2-ethylhexyl) phthalate decreases expression ISO Slc25a30 (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of SLC25A30 mRNA CTD PMID:22401849 Slc25a30 Rat N-nitrosodiethylamine increases expression ISO Slc25a30 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of SLC25A30 mRNA CTD PMID:24535843 Slc25a30 Rat N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SLC25A30 mRNA CTD PMID:22129741 Slc25a30 Rat N-nitrosodiethylamine multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of SLC25A30 mRNA CTD PMID:24535843 Slc25a30 Rat N-nitrosodimethylamine affects expression EXP 6480464 Dimethylnitrosamine affects the expression of SLC25A30 mRNA CTD PMID:25380136 Slc25a30 Rat nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of SLC25A30 mRNA CTD PMID:24136188 Slc25a30 Rat nickel sulfate decreases expression ISO SLC25A30 (Homo sapiens) 6480464 nickel sulfate results in decreased expression of SLC25A30 mRNA CTD PMID:22714537 Slc25a30 Rat oxycodone decreases expression EXP 6480464 Oxycodone results in decreased expression of SLC25A30 mRNA CTD PMID:23439660 Slc25a30 Rat paracetamol affects expression ISO Slc25a30 (Mus musculus) 6480464 Acetaminophen affects the expression of SLC25A30 mRNA CTD PMID:17562736 Slc25a30 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC25A30 mRNA CTD PMID:33387578 Slc25a30 Rat paracetamol increases expression ISO SLC25A30 (Homo sapiens) 6480464 Acetaminophen results in increased expression of SLC25A30 mRNA CTD PMID:29067470 Slc25a30 Rat paracetamol decreases expression ISO SLC25A30 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of SLC25A30 mRNA CTD PMID:25704631 Slc25a30 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC25A30 mRNA more ... CTD PMID:36331819 Slc25a30 Rat perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of SLC25A30 mRNA CTD PMID:19162173 Slc25a30 Rat perfluorooctanoic acid multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SLC25A30 mRNA CTD PMID:35163327 Slc25a30 Rat perfluorooctanoic acid increases expression ISO SLC25A30 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of SLC25A30 mRNA CTD PMID:32588087 Slc25a30 Rat phenobarbital decreases expression ISO Slc25a30 (Mus musculus) 6480464 Phenobarbital results in decreased expression of SLC25A30 mRNA CTD PMID:19482888 Slc25a30 Rat phenobarbital multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of SLC25A30 mRNA CTD PMID:24535843 Slc25a30 Rat phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of SLC25A30 mRNA CTD PMID:19162173 Slc25a30 Rat pirinixic acid multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC25A30 mRNA CTD PMID:18489776 Slc25a30 Rat pirinixic acid affects expression ISO Slc25a30 (Mus musculus) 6480464 pirinixic acid affects the expression of SLC25A30 mRNA CTD PMID:23811191 Slc25a30 Rat pirinixic acid increases expression ISO Slc25a30 (Mus musculus) 6480464 pirinixic acid results in increased expression of SLC25A30 mRNA CTD PMID:17426115 and PMID:18301758 Slc25a30 Rat pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of SLC25A30 mRNA CTD PMID:19162173 and PMID:32741897 Slc25a30 Rat pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of SLC25A30 mRNA CTD PMID:19162173 Slc25a30 Rat quercetin increases expression ISO SLC25A30 (Homo sapiens) 6480464 Quercetin results in increased expression of SLC25A30 mRNA CTD PMID:21632981 Slc25a30 Rat rac-lactic acid decreases expression ISO SLC25A30 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of SLC25A30 mRNA CTD PMID:30851411 Slc25a30 Rat riddelliine decreases expression EXP 6480464 riddelliine results in decreased expression of SLC25A30 mRNA CTD PMID:18047722 Slc25a30 Rat SB 431542 multiple interactions ISO SLC25A30 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A30 mRNA CTD PMID:27188386 Slc25a30 Rat silicon dioxide decreases expression ISO Slc25a30 (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of SLC25A30 mRNA CTD PMID:23221170 Slc25a30 Rat sodium arsenate increases expression ISO Slc25a30 (Mus musculus) 6480464 sodium arsenate results in increased expression of SLC25A30 mRNA CTD PMID:30953684 Slc25a30 Rat sodium arsenite increases expression ISO Slc25a30 (Mus musculus) 6480464 sodium arsenite results in increased expression of SLC25A30 mRNA CTD PMID:22700541 Slc25a30 Rat sodium arsenite multiple interactions ISO SLC25A30 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC25A30 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC25A30 mRNA CTD PMID:39836092 Slc25a30 Rat sodium arsenite affects expression ISO Slc25a30 (Mus musculus) 6480464 sodium arsenite affects the expression of SLC25A30 mRNA CTD PMID:25825268 Slc25a30 Rat sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of SLC25A30 mRNA CTD PMID:25993096 Slc25a30 Rat sunitinib increases expression ISO SLC25A30 (Homo sapiens) 6480464 Sunitinib results in increased expression of SLC25A30 mRNA CTD PMID:31533062 Slc25a30 Rat tamoxifen affects expression ISO Slc25a30 (Mus musculus) 6480464 Tamoxifen affects the expression of SLC25A30 mRNA CTD PMID:20937368 Slc25a30 Rat testosterone increases expression ISO Slc25a30 (Mus musculus) 6480464 Testosterone results in increased expression of SLC25A30 mRNA CTD PMID:21669218 Slc25a30 Rat testosterone decreases expression ISO Slc25a30 (Mus musculus) 6480464 Testosterone deficiency results in decreased expression of SLC25A30 mRNA CTD PMID:33848595 Slc25a30 Rat tetrachloroethene increases expression ISO Slc25a30 (Mus musculus) 6480464 Tetrachloroethylene results in increased expression of SLC25A30 mRNA CTD PMID:28973375 Slc25a30 Rat tetrachloromethane increases expression ISO Slc25a30 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of SLC25A30 mRNA CTD PMID:27339419 Slc25a30 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC25A30 mRNA CTD PMID:30723492 and PMID:31150632 Slc25a30 Rat tetracycline increases expression ISO Slc25a30 (Mus musculus) 6480464 Tetracycline results in increased expression of SLC25A30 mRNA CTD PMID:16917069 Slc25a30 Rat thalidomide decreases expression ISO Slc25a30 (Mus musculus) 6480464 Thalidomide results in decreased expression of SLC25A30 mRNA CTD PMID:26217789 Slc25a30 Rat titanium dioxide decreases methylation ISO Slc25a30 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of SLC25A30 gene CTD PMID:35295148 Slc25a30 Rat trichostatin A increases expression ISO SLC25A30 (Homo sapiens) 6480464 trichostatin A results in increased expression of SLC25A30 mRNA CTD PMID:24935251 Slc25a30 Rat trichostatin A affects expression ISO SLC25A30 (Homo sapiens) 6480464 trichostatin A affects the expression of SLC25A30 mRNA CTD PMID:28542535 Slc25a30 Rat triphenyl phosphate affects expression ISO SLC25A30 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of SLC25A30 mRNA CTD PMID:37042841 Slc25a30 Rat troglitazone decreases expression ISO Slc25a30 (Mus musculus) 6480464 troglitazone results in decreased expression of SLC25A30 mRNA CTD PMID:28973697 Slc25a30 Rat valproic acid affects expression ISO SLC25A30 (Homo sapiens) 6480464 Valproic Acid affects the expression of SLC25A30 mRNA CTD PMID:25979313 Slc25a30 Rat valproic acid increases expression ISO SLC25A30 (Homo sapiens) 6480464 Valproic Acid results in increased expression of SLC25A30 mRNA CTD PMID:19101580 more ... Slc25a30 Rat valproic acid multiple interactions ISO SLC25A30 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A30 mRNA CTD PMID:27188386 Slc25a30 Rat vorinostat increases expression ISO SLC25A30 (Homo sapiens) 6480464 vorinostat results in increased expression of SLC25A30 mRNA CTD PMID:27188386 Slc25a30 Rat zinc atom multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SLC25A30 mRNA CTD PMID:33549593 Slc25a30 Rat zinc(0) multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SLC25A30 mRNA CTD PMID:33549593